EAM
TEVA icon

EverPoint Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

EverPoint Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-200,000
Closed -$10.5M – 533
2014
Q2 		$10.5M Buy
+200,000
New +$10.2M 0.22% 135

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EverPoint Asset Management's TEVA Position: Q1 2016 in Review

EverPoint Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 450,000 shares — an estimated $29.5M sold.

EverPoint Asset Management first reported a position in TEVA in Q2 2014 and held it in 7 quarters. The position peaked at $55M in Q2 2014. 836 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

  • EverPoint Asset Management reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • EverPoint Asset Management sold 450,000 Teva Pharmaceuticals shares in Q1 2016, an estimated $29.5M.
  • EverPoint Asset Management first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 7 quarters.
  • EverPoint Asset Management's Teva Pharmaceuticals position peaked at $55M in Q2 2014.
  • 836 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on EverPoint Asset Management's 13F filing for Q1 2016, filed 16 May 2016.